Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tryptophan metabolites and brain disorders.

Trevor W Stone1, Gillian M Mackay, Caroline M Forrest

  • 1Institute of Biomedical & Life Sciences,Division of Neuroscience & Biomedical Systems, West Medical Building, University of Glasgow, Glasgow, UK. T.W.Stone@bio.gla.ac.uk

Clinical Chemistry and Laboratory Medicine
|August 28, 2003
PubMed
Summary

The kynurenine pathway affects brain cells. Some metabolites are neurotoxic, while others are neuroprotective, suggesting potential new treatments for neurological disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab.

Cell reports·2026
Same author

Potential regulation of kynurenine pathway metabolism by the galantamine-memantine combination in rheumatologic diseases: A hypothesis-driven review.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Paradoxical Expression of Ionotropic Glutamate Receptors in Leucocytes.

Clinical reviews in allergy & immunology·2026
Same author

The Contribution of Paresis, Age, and the Effect of Short Training on Cognitive-Motor Dual-Task Interference After Stroke: A Pilot Study.

Life (Basel, Switzerland)·2025
Same author

Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled Trials.

Clinical drug investigation·2025
Same author

Galantamine-Memantine Combination in the Treatment of Parkinson's Disease Dementia.

Brain sciences·2025

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Tryptophan metabolism involves the kynurenine pathway.
  • Key metabolites, quinolinic acid and kynurenic acid, impact central nervous system (CNS) neurons.
  • Dysregulation of these metabolites is linked to CNS disorders.

Purpose of the Study:

  • To investigate the neuroactive properties of kynurenine pathway metabolites.
  • To explore the potential therapeutic implications of modulating kynurenine pathway activity.

Main Methods:

  • Analysis of kynurenine pathway metabolite concentrations.
  • Assessment of neuroactivity, including receptor interactions and free radical generation.

Main Results:

Related Experiment Videos

  • Quinolinic acid acts as an N-methyl-D-aspartate (NMDA) receptor agonist, exhibiting neurotoxic effects.
  • Kynurenic acid functions as a glutamate receptor antagonist, demonstrating neuroprotective properties.
  • 3-hydroxykynurenine contributes to oxidative stress and neuronal damage.

    • Conclusions:

    • The balance of kynurenine pathway metabolites is critical for neuronal function.
    • Aberrant levels of these metabolites are implicated in neurological conditions like AIDS-dementia and Huntington's disease.
    • Targeting the kynurenine pathway offers potential for novel pharmacotherapies for CNS disorders.